It's not the sky that's falling, it's the status quo

Share this article:
Bobbie ­Montgomery is SVP, healthcare practice, Technekes
Bobbie ­Montgomery is SVP, healthcare practice, Technekes

The sky is not falling.

Yes, a recent Wall Street Journal article lists these facts:

• Pharmaceutical sales forces have been slashed by an average 30%.

• 22% of medical professionals implement “no see” policies in their practices.

• Marketing budgets have been pared some 15% in the past five years.

However, I've been in the business for nearly 30 years, and I say with assurance that the sales landscape is more promising than ever.  Traditional sales may have gone the way of the little glen plaid suit I wore back in the day, but to both, I say, “so long.”

Although the sky is not falling, I readily acknowledge that the horizon is changing and increasingly challenging.  This, however, can be a good and promising thing for pharmaceutical manufacturers and marketers alike.

Not enough sales reps?  This is easily resolved.  After all, frequency is the name of the game, and with proper strategy, planning and technology, I can now reach a lot more physicians—a lot more often and with far more relevant messages—with personalized letters, faxes and emails.  Indeed, we're finding that our integrated efforts can garner significantly higher response rates than traditional methods.

Doctors don't have time for rep office visits?  Why should they, when we can reach them on their schedule, with virtual reps, video channels and mobile apps?  In my experience, online sales reps often outperform their field-based counterparts, making sales while saving manufacturers time and money.

No more tchotchkes for the staff?  Who needs them when we've proven that a program with samples and co-pay cards can yield 4X ROI?

The key is harnessing these new marketing and sales techniques.  And there's the rub.  Today's pharma marketer has to adapt—controlling what could be chaos, orchestrating the techniques into a logical, trackable sequence, and measuring performance and behavior along the way.  The point isn't to simply throw marketing strategies at the problem.  As always, it is to build and maintain relationships.

With that in mind, today's pharma marketer can realize more opportunities than ever.  The sky isn't falling.  Indeed, in today's market, the sky may be the limit.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: HealthSpot's teleconnected CEO

Headliner: HealthSpot's teleconnected CEO

Steve Cashman, Founder and CEO, HealthSpot

Recruitment: The New Breed

Recruitment: The New Breed

What do healthcare agencies really want when it comes to potential employees? The answer to that question is in a constant state of flux, as technologies, clients' changing demands and ...

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the September 2014 issue of MM&M, with all text, charts and pictures.